Omixon Inc.

Omixon Inc. is a leading molecular diagnostics company focused on advancing HLA typing through next-generation sequencing technologies. Their flagship product, Holotype HLA™, is designed to enhance transplant outcomes by providing accurate genetic testing for histocompatibility labs.